|
|
 |
|
Total Number of Holdings (excluding cash): 48
| Johnson & Johnson |
JNJ |
478160104 |
Pharmaceuticals |
6,956 |
$1,233,994.40 |
8.05% |
| AbbVie Inc. |
ABBV |
00287Y109 |
Pharmaceuticals |
5,494 |
$1,195,549.34 |
7.80% |
| Pfizer Inc. |
PFE |
717081103 |
Pharmaceuticals |
43,450 |
$1,041,496.50 |
6.79% |
| Merck & Co., Inc. |
MRK |
58933Y105 |
Pharmaceuticals |
12,449 |
$1,008,617.98 |
6.58% |
| Bristol-Myers Squibb Company |
BMY |
110122108 |
Pharmaceuticals |
19,265 |
$892,932.75 |
5.82% |
| United Therapeutics Corporation |
UTHR |
91307C102 |
Pharmaceuticals |
1,795 |
$723,582.45 |
4.72% |
| Viatris Inc. |
VTRS |
92556V106 |
Pharmaceuticals |
62,238 |
$597,484.80 |
3.90% |
| Biogen Inc. |
BIIB |
09062X103 |
Biotechnology |
4,089 |
$586,035.48 |
3.82% |
| Gilead Sciences, Inc. |
GILD |
375558103 |
Pharmaceuticals |
5,025 |
$565,513.50 |
3.69% |
| Amgen Inc. |
AMGN |
031162100 |
Pharmaceuticals |
1,859 |
$510,109.60 |
3.33% |
| Zoetis Inc. |
ZTS |
98978V103 |
Pharmaceuticals |
3,424 |
$500,760.00 |
3.27% |
| Jazz Pharmaceuticals Plc |
JAZZ |
G50871105 |
Pharmaceuticals |
3,989 |
$499,502.58 |
3.26% |
| Regeneron Pharmaceuticals, Inc. |
REGN |
75886F107 |
Biotechnology |
819 |
$468,951.21 |
3.06% |
| Eli Lilly and Company |
LLY |
532457108 |
Pharmaceuticals |
622 |
$465,374.18 |
3.04% |
| Elanco Animal Health Incorporated |
ELAN |
28414H103 |
Pharmaceuticals |
23,419 |
$436,530.16 |
2.85% |
| Medpace Holdings, Inc. |
MEDP |
58506Q109 |
Biotechnology |
870 |
$431,876.70 |
2.82% |
| Exelixis, Inc. |
EXEL |
30161Q104 |
Biotechnology |
7,821 |
$305,097.21 |
1.99% |
| Charles River Laboratories International, Inc. |
CRL |
159864107 |
Biotechnology |
1,987 |
$302,500.88 |
1.97% |
| Illumina, Inc. |
ILMN |
452327109 |
Biotechnology |
2,996 |
$302,356.32 |
1.97% |
| Organon & Co. |
OGN |
68622V106 |
Pharmaceuticals |
27,775 |
$288,860.00 |
1.88% |
| Halozyme Therapeutics, Inc. |
HALO |
40637H109 |
Biotechnology |
3,636 |
$277,535.88 |
1.81% |
| Neurocrine Biosciences, Inc. |
NBIX |
64125C109 |
Biotechnology |
1,811 |
$254,336.84 |
1.66% |
| BioMarin Pharmaceutical Inc. |
BMRN |
09061G101 |
Pharmaceuticals |
2,815 |
$149,589.10 |
0.98% |
| Amneal Pharmaceuticals, Inc. |
AMRX |
03168L105 |
Pharmaceuticals |
15,230 |
$149,101.70 |
0.97% |
| Alnylam Pharmaceuticals, Inc. |
ALNY |
02043Q107 |
Biotechnology |
320 |
$147,564.80 |
0.96% |
| Insmed Incorporated |
INSM |
457669307 |
Biotechnology |
968 |
$138,559.52 |
0.90% |
| Alkermes Plc |
ALKS |
G01767105 |
Pharmaceuticals |
5,110 |
$135,517.20 |
0.88% |
| Perrigo Company Plc |
PRGO |
G97822103 |
Pharmaceuticals |
5,203 |
$113,165.25 |
0.74% |
| Guardant Health, Inc. |
GH |
40131M109 |
Biotechnology |
1,855 |
$101,635.45 |
0.66% |
| ACADIA Pharmaceuticals Inc. |
ACAD |
004225108 |
Biotechnology |
4,028 |
$99,370.76 |
0.65% |
| Madrigal Pharmaceuticals, Inc. |
MDGL |
558868105 |
Biotechnology |
231 |
$98,313.60 |
0.64% |
| Cardinal Health, Inc. |
CAH |
14149Y108 |
Pharmaceuticals |
610 |
$91,664.70 |
0.60% |
| Catalyst Pharmaceuticals, Inc. |
CPRX |
14888U101 |
Biotechnology |
4,694 |
$92,753.44 |
0.60% |
| Corcept Therapeutics Inc. |
CORT |
218352102 |
Pharmaceuticals |
1,303 |
$90,597.59 |
0.59% |
| Exact Sciences Corporation |
EXAS |
30063P105 |
Biotechnology |
1,665 |
$88,960.95 |
0.58% |
| Incyte Corporation |
INCY |
45337C102 |
Biotechnology |
1,074 |
$89,292.36 |
0.58% |
| Prestige Consumer Healthcare Inc. |
PBH |
74112D101 |
Pharmaceuticals |
1,402 |
$88,283.94 |
0.58% |
| PTC Therapeutics, Inc. |
PTCT |
69366J200 |
Biotechnology |
1,429 |
$84,282.42 |
0.55% |
| TG Therapeutics, Inc. |
TGTX |
88322Q108 |
Biotechnology |
2,624 |
$83,312.00 |
0.54% |
| ADMA Biologics, Inc. |
ADMA |
000899104 |
Biotechnology |
4,817 |
$73,700.10 |
0.48% |
| Axsome Therapeutics, Inc. |
AXSM |
05464T104 |
Biotechnology |
619 |
$72,283.74 |
0.47% |
| Veracyte, Inc. |
VCYT |
92337F107 |
Biotechnology |
2,271 |
$72,376.77 |
0.47% |
| Akero Therapeutics, Inc. |
AKRO |
00973Y108 |
Biotechnology |
1,607 |
$68,859.95 |
0.45% |
| Krystal Biotech, Inc. |
KRYS |
501147102 |
Biotechnology |
440 |
$68,512.40 |
0.45% |
| Scholar Rock Holding Corporation |
SRRK |
80706P103 |
Biotechnology |
2,034 |
$68,484.78 |
0.45% |
| Vertex Pharmaceuticals Incorporated |
VRTX |
92532F100 |
Pharmaceuticals |
165 |
$64,879.65 |
0.42% |
| US Dollar |
$USD |
|
Other |
51,420 |
$51,419.80 |
0.34% |
| Vericel Corporation |
VCEL |
92346J108 |
Biotechnology |
1,539 |
$48,355.38 |
0.32% |
| Sarepta Therapeutics, Inc. |
SRPT |
803607100 |
Biotechnology |
740 |
$12,927.80 |
0.08% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|